Introduction: A history of transurethral surgery of the prostate is generally considered as a risk factor of adverse functional outcomes after radical prostatectomy (RP). We tested whether the risk of postoperative urinary incontinence (UIC) and erectile dysfunction (ED) after RP could be further substantiated in such patients. Materials and Methods: We tested the effect of the following variables on UIC and ED rates 1 year after RP: residual prostate volume after transurethral desobstruction, the time from transurethral desobstruction to RP, the type of transurethral desobstruction (TURP vs. laser enucleation), age, and nerve-sparing surgery (yes vs. no). UIC was defined as usage of any pad except a safety pad. ED was defined as no sexual intercourse possible. Results: Overall, 216 patients treated with RP between 2010 and 2019 in a tertiary care center were evaluated. All patients had previously undergone transurethral desobstruction. Regarding UIC analyses, only time from transurethral desobstruction to RP significantly influenced UIC rates (p = 0.003). Regarding ED rates, none of the tested variables reached statistical significance. Conclusion: The risk of UIC and ED after RP is substantial in men who had previously undergone transurethral desobstruction. The time from transurethral desobstruction to RP significantly impacts on the postoperative UIC rates. This observation should be further explored in future studies.

1.
Walsh
PC
,
Donker
PJ
.
Impotence following radical prostatectomy: insight into etiology and prevention
.
J Urol
.
1982 Sep
;
128
(
3
):
492
7
. .
2.
Walsh
PC
,
Lepor
H
,
Eggleston
JC
.
Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations
.
Prostate
.
1983
;
4
(
5
):
473
85
. .
3.
Schlomm
T
,
Heinzer
H
,
Steuber
T
,
Salomon
G
,
Engel
O
,
Michl
U
, et al
Full functional-length urethral sphincter preservation during radical prostatectomy
.
Eur Urol
.
2011
;
60
(
2
):
320
9
. .
4.
Antonelli
A
,
Palumbo
C
,
Noale
M
,
Porreca
A
,
Maggi
S
,
Simeone
C
, et al
Impact of surgical approach on patient-reported outcomes after radical prostatectomy: a propensity score-weighted analysis from a multicenter, prospective, observational study (The Pros-IT CNR Study)
.
Urol Int
.
2019
;
103
(
1
):
8
18
. .
5.
Wei
Y
,
Wu
YP
,
Lin
MY
,
Chen
SH
,
Lin
YZ
,
Li
XD
, et al
Impact of obesity on long-term urinary incontinence after radical prostatectomy: a meta-analysis
.
Biomed Res Int
.
2018 Apr
;
2018
:
8279523
. .
6.
Ficarra
V
,
Novara
G
,
Rosen
RC
,
Artibani
W
,
Carroll
PR
,
Costello
A
, et al
Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy
.
Eur Urol
.
2012 Sep
;
62
(
3
):
405
17
. .
7.
Ficarra
V
,
Novara
G
,
Ahlering
TE
,
Costello
A
,
Eastham
JA
,
Graefen
M
, et al
Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy
.
Eur Urol
.
2012 Sep
;
62
(
3
):
418
30
. .
8.
Pompe
RS
,
Leyh-Bannurah
SR
,
Preisser
F
,
Salomon
G
,
Graefen
M
,
Huland
H
, et al
Radical prostatectomy after previous TUR-P: oncological, surgical, and functional outcomes
.
Urol Oncol
.
2018 Dec
;
36
(
12
):
527.e21
527.e28
. .
9.
Colombo
R
,
Naspro
R
,
Salonia
A
,
Montorsi
F
,
Raber
M
,
Suardi
N
, et al
Radical prostatectomy after previous prostate surgery: clinical and functional outcomes
.
J Urol
.
2006 Dec
;
176
(
6 Pt 1
):
2459
63
; discussion 63. .
10.
Palisaar
JR
,
Wenske
S
,
Sommerer
F
,
Hinkel
A
,
Noldus
J
.
Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate
.
BJU Int
.
2009 Sep
;
104
(
5
):
611
5
. .
11.
Adam
M
,
Tennstedt
P
,
Lanwehr
D
,
Tilki
D
,
Steuber
T
,
Beyer
B
, et al
Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy
.
Eur Urol
.
2017 Mar
;
71
(
3
):
330
6
. .
12.
Haglind
E
,
Carlsson
S
,
Stranne
J
,
Wallerstedt
A
,
Wilderäng
U
,
Thorsteinsdottir
T
, et al
Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial
.
Eur Urol
.
2015 Aug
;
68
(
2
):
216
25
. .
13.
Mottet
N
,
Bellmunt
J
,
Bolla
M
,
Briers
E
,
Cumberbatch
MG
,
De Santis
M
, et al
EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
.
Eur Urol
.
2017 Apr
;
71
(
4
):
618
29
. .
14.
Haese
A
,
Knipper
S
,
Isbarn
H
,
Heinzer
H
,
Tilki
D
,
Salomon
G
, et al
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures
.
BJU Int
.
2019 Jun
;
123
(
6
):
1031
40
. .
15.
Zugor
V
,
Labanaris
AP
,
Porres
D
,
Witt
JH
.
Surgical, oncologic, and short-term functional outcomes in patients undergoing robot-assisted prostatectomy after previous transurethral resection of the prostate
.
J Endourol
.
2012 May
;
26
(
5
):
515
9
. .
16.
Li
H
,
Zhao
C
,
Liu
P
,
Hu
J
,
Yi
Z
,
Chen
J
, et al
Radical prostatectomy after previous transurethral resection of the prostate: a systematic review and meta-analysis
.
Transl Androl Urol
.
2019 Dec
;
8
(
6
):
712
27
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.